Oliver Lagore Vanvalin Investment Group Abbott Laboratories Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Abbott Laboratories stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 334 shares of ABT stock, worth $44,849. This represents 0.02% of its overall portfolio holdings.
Number of Shares
334
Previous 334
-0.0%
Holding current value
$44,849
Previous $37,000
21.62%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.38BCall Options Held
9.71MPut Options Held
8.86M-
Vanguard Group Inc Valley Forge, PA170MShares$22.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.97 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.81 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...